secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZyVersa Therapeutics, Inc. (ZVSA)
CIK:        0001859007
Form:       8-K
Filed at:   2024-11-06T23:59:59+00:00
Accession:  0001493152-24-043754
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ZyVersa raises ~$1.7M via warrant exercise inducement at $2.06/share
--------------------------------------------------------------------

- Existing warrant holders exercise at reduced price of $2.06/share; gross proceeds ~$1.7M.
- Company issues new Series A-2 warrants for 200% of exercised shares, exercise price $2.06, 5-year term.
- Engaged A.G.P./Alliance Global Partners as financial advisor; cash fee $110,000 plus $10k expenses.
- Net proceeds for working capital and general corporate purposes.
- Company to file resale registration statement for new warrant shares by Dec 20, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859007/000149315224043754/0001493152-24-043754-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859007/000149315224043754/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-043754

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer